Pneumocystis jirovecii DNA in Serum for the Diagnosis of Pneumocystis Pneumonia in Patients with Hematologic Malignancies—A Retrospective Case Control Study
Journal of Fungi · 20.07.2026 · 12 (7) · 534
DOI: 10.3390/jof12070534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 20.07.2026. Verfasst von Caroline Ström Turesson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Göteborg Medical Siciety, Gothenburg Medical Society.
Abstract (Originalsprache)
Diagnosis of Pneumocystis jirovecii pneumonia (PCP) relies on lower respiratory tract sampling, often requiring bronchoscopy. Given its invasive nature, non-invasive diagnostic methods are desirable. In this retrospective case–control study, we evaluated the diagnostic performance of serum P. jirovecii PCR and β-D-glucan for PCP diagnosis. Adult patients with hematologic malignancies and positive P. jirovecii PCR in lower respiratory tract samples were included as cases and classified as PCP or colonization. Controls had negative BAL PCR. Stored serum samples were analyzed by P. jirovecii PCR and β-D-glucan. Forty-one cases (29 PCP, 12 colonization) and 36 controls were included. Serum P. jirovecii PCR was positive in 20/41 cases (49%) and in 15/29 patients with PCP (52%), while no controls were serum PCR-positive. For PCP diagnosis, serum PCR had a sensitivity of 52% and a specificity of 89%. For detection of P. jirovecii in the lower respiratory tract, sensitivity was 49% and specificity 100%. Detectable serum P. jirovecii DNA was associated with higher P. jirovecii load in respiratory tract samples and higher β-D-glucan levels, but not with the presence or severity of pneumonia. Serum P. jirovecii PCR is a highly specific marker of P. jirovecii in the lower respiratory tract and may serve as a useful initial non-invasive test in patients with suspected PCP, prior to invasive respiratory sampling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.
- Department of Clinical Microbiology, Sahlgrenska University Hospital, Region Västra Götaland, 402 34 Gothenburg, Sweden.
- Department of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, 416 85 Gothenburg, Sweden.
ORCID-Profile: Helena Hammarström
Förderung
- Göteborg Medical Siciety
- Gothenburg Medical Society
Zitieren
APA
Ström Turesson, C., Grankvist, A., & Hammarström, H. (2026). Pneumocystis jirovecii DNA in Serum for the Diagnosis of Pneumocystis Pneumonia in Patients with Hematologic Malignancies—A Retrospective Case Control Study. Journal of Fungi, 12(7), 534. https://doi.org/10.3390/jof12070534
Vancouver
Ström Turesson C, Grankvist A, Hammarström H. Pneumocystis jirovecii DNA in Serum for the Diagnosis of Pneumocystis Pneumonia in Patients with Hematologic Malignancies—A Retrospective Case Control Study. Journal of Fungi. 2026;12(7):534. doi:10.3390/jof12070534
BibTeX
@article{StrmTuresson2026,
author = {Ström Turesson, Caroline and Grankvist, Anna and Hammarström, Helena},
title = {Pneumocystis jirovecii DNA in Serum for the Diagnosis of Pneumocystis Pneumonia in Patients with Hematologic Malignancies—A Retrospective Case Control Study},
journal = {Journal of Fungi},
year = {2026},
volume = {12},
number = {7},
pages = {534},
doi = {10.3390/jof12070534}
}
EUVIMED